Cargando…

RAGE pathway activation and function in chronic kidney disease and COVID-19

The multi-ligand receptor for advanced glycation end-products (RAGE) and its ligands are contributing factors in autoimmunity, cancers, and infectious disease. RAGE activation is increased in chronic kidney disease (CKD) and coronavirus disease 2019 (COVID-19). CKD may increase the risk of COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Curran, Colleen S., Kopp, Jeffrey B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395689/ https://www.ncbi.nlm.nih.gov/pubmed/36017003 http://dx.doi.org/10.3389/fmed.2022.970423

Ejemplares similares

Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease
por: Curran, Colleen S., et al.
Publicado: (2022)

The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease
por: Curran, Colleen S., et al.
Publicado: (2023)

Description of an Integrated and Dynamic System to Efficiently Deal With a Raging COVID-19 Pandemic Peak
por: Agnoletti, Vanni, et al.
Publicado: (2022)

COVID-19 Usurps Host Regulatory Networks
por: Curran, Colleen S., et al.
Publicado: (2020)

Glomerular Kidney Diseases in the Single-Cell Era
por: Latt, Khun Zaw, et al.
Publicado: (2021)

RAGE has potential pathogenetic and prognostic value in nonintubated hospitalized patients with COVID-19
por: Wick, Katherine D., et al.
Publicado: (2022)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021)

Chronic Kidney Diseases and Acute Kidney Injury in Patients With COVID-19: Evidence From a Meta-Analysis
por: Zhou, Yangzhong, et al.
Publicado: (2020)

Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients
por: Torino, Claudia, et al.
Publicado: (2017)

Nationwide in-hospital mortality and morbidity analysis of COVID-19 in advanced chronic kidney disease, dialysis and kidney transplant recipients
por: He, Mingyue, et al.
Publicado: (2023)

RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease
por: Robinson, Adam B., et al.
Publicado: (2012)

Exercise plus caloric restriction lowers soluble RAGE in adults with chronic kidney disease
por: Malin, Steven K., et al.
Publicado: (2020)

HIV and chronic kidney disease
por: Naicker, Saraladevi, et al.
Publicado: (2015)

Impacts of COVID-19 Pandemic on Psychological Well-Being of Older Chronic Kidney Disease Patients
por: Chan, Alex Siu Wing, et al.
Publicado: (2021)

Raging Diseases
Publicado: (1870)

-374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease
por: Baragetti, Ivano, et al.
Publicado: (2013)

PD-1 immunobiology in glomerulonephritis and renal cell carcinoma
por: Curran, Colleen S., et al.
Publicado: (2021)

Microbiome, Immunosenescence, and Chronic Kidney Disease
por: Stavropoulou, Elisavet, et al.
Publicado: (2021)

The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries
por: Salehi, Mitra, et al.
Publicado: (2022)

Methodological challenges and biases in the field of cognitive function among patients with chronic kidney disease
por: Giannakou, Konstantinos, et al.
Publicado: (2023)

Correlation and Diagnostic Value of Serum RBP4 and sRAGE and the Condition of Patients with Chronic Kidney Disease
por: Xiong, Shihong, et al.
Publicado: (2021)

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro
por: Miller, Suzanne, et al.
Publicado: (2016)

Heparan sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE
por: Li, Miaomiao, et al.
Publicado: (2022)

Changes in Mortality According to Creatinine/Cystatin C Ratio in Chronic Kidney Disease and Non-chronic Kidney Disease Patients
por: Hwang, Jeong Ah, et al.
Publicado: (2022)

COVID-19 and Diabetes: The Importance of Controlling RAGE
por: De Francesco, Ernestina M., et al.
Publicado: (2020)

Diabetic Kidney Disease and COVID-19: The Crash of Two Pandemics
por: D'Marco, Luis, et al.
Publicado: (2020)

Underlying Kidney Diseases and Complications for COVID-19: A Review
por: Dadson, Prince, et al.
Publicado: (2020)

Exercise modulates sympathetic and vascular function in chronic kidney disease
por: Jeong, Jinhee, et al.
Publicado: (2023)

Male Sexual Dysfunction and Chronic Kidney Disease
por: Edey, Matthew M.
Publicado: (2017)

Therapeutic Insights in Chronic Kidney Disease Progression
por: Shabaka, Amir, et al.
Publicado: (2021)

Editorial: Genetics and epigenetics of chronic kidney disease
por: Hoefele, Julia, et al.
Publicado: (2023)

COVID-19 and the Kidneys: An Update
por: Benedetti, Claudia, et al.
Publicado: (2020)

Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19—The Role of RAGE-RAS Crosstalk
por: Chiappalupi, Sara, et al.
Publicado: (2021)

Hematological Abnormalities in COVID-19 Disease: Association With Type I Interferon Pathway Activation and Disease Outcomes
por: Georgakopoulou, Vasiliki E., et al.
Publicado: (2022)

Early Chronic Kidney Disease Care Programme delays kidney function deterioration in patients with stage I–IIIa chronic kidney disease: an observational cohort study in Taiwan
por: Niu, Shu-Fen, et al.
Publicado: (2021)

Shedding of Klotho: Functional Implications in Chronic Kidney Disease and Associated Vascular Disease
por: Saar-Kovrov, Valeria, et al.
Publicado: (2021)

CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver
por: Pang, Qiwen, et al.
Publicado: (2020)

Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD
por: Gopal, Poornima, et al.
Publicado: (2014)

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
por: Wu, Rui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_414bkr9es8tdvpgpkp2gq4dksp